05
Tue, Aug

From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health

From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health

Financial News
From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health

Fellow Healthjust raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services.

Fellow Health provides clinical grade, mail-in analysis of male fertility and post-vasectomy status while committing to "privacy, convenience and timely results." Italready has a network of more than 2,500 fertility and urology providers nationwide and wants to "deepen its footprint" through expansion into employer-sponsored fertility benefits and "broader access initiatives."

Don't Miss:

5AM Ventures led the latest funding round, in which asset management firm Forest Road participated for the first time. Forest Managing Partner of Life Sciences Bill Burkoth will join Fellow's board as part of the financing deal. Other investors since the initial round include Labcorp Venture Fund, Genoa Ventures and Mantis Venture Capital.

"Fellow Health is exactly the kind of company we look for – operating in a large, overlooked market that's long overdue for disruption," Burkoth said in a statement. "With over 50,000 test results delivered so far this year, they've proven there is real demand for a better patient experience."

Live sperm gets counted in fertility analysis. These cells can live three to days within the cervix, uterus and fallopian tubes, but usually die in under an hour outside a woman's body. The mail-in service addresses this time bomb with a "preservation solution designed to stabilize your sample and a gel pack that helps maintain a moderate temperature during transit." Mail-in post-vasectomy testing is less time critical because it counts both living and dead sperm.

Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share.

Fellow Health points to studies backing up its claim that it can provide "results on par with traditional one-hour semen analysis when analyzing samples received within 52 hours of when they were produced." It sells both testing products and a cryopreservation service without a doctor's prescription at its website.

Content Original Link:

Original Source At Yahoo Finance

" target="_blank">

Original Source At Yahoo Finance

SILVER ADVERTISERS

BRONZE ADVERTISERS

Infomarine banners

Advertise in Maritime Directory

Publishers

Publishers